Market cap
₹623 cr
Loading the extract…
Healthcare · Pharmaceuticals
KRMAYURVED · NSE KRMAYURVED
Market cap
₹623 cr
Price
293
52w high
303
52w low
156
PE
31
Industry PE
—
Book value
54
Dividend yield
0%
ROCE
35.3
ROE
29
Debt / equity
—
EPS
—
No description in this extract.
| Line | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Depreciation | 1 | 1 | 1 | 1 |
| Dividend Payout % | 0 | 0 | 0 | 0 |
| EPS in Rs | 9.46 | 806.67 | 2,273.33 | 5,066.67 |
| Expenses | 71 | 57 | 60 | 78 |
| Interest | 3 | 2 | 2 | 1 |
| Net Profit | 20 | 12 | 3 | 8 |
| OPM % | 30 | 25 | 11 |
| Line | 2026-03-31 | 2025-09-30 | 2025-03-31 |
|---|---|---|---|
| Depreciation | 1 | 1 | 1 |
| EPS in Rs | 5.6 | 5.24 | 318.67 |
| Expenses | 36 | 36 | 32 |
| Interest | 2 | 2 | 2 |
| Net Profit | 12 | 8 | 5 |
| OPM % | 33 | 27 | 21 |
| Operating Profit | 18 | 13 | 8 |
| Other Income | 0 | 0 | 0 |
| Line | 2026-03-31 |
|---|---|
| DIIs | 3.34 |
| FIIs | 3.86 |
| Promoters | 69.15 |
| Public | 23.65 |
| 13 |
| Operating Profit | 30 | 19 | 8 | 11 |
| Other Income | 1 | 0 | 0 | 0 |
| Profit before tax | 27 | 16 | 5 | 10 |
| Sales | 102 | 77 | 67 | 89 |
| Tax % | 25 | 26 | 28 | 25 |
| Profit before tax | 16 | 11 | 6 |
| Raw PDF | — | — | — |
| Sales | 53 | 48 | 41 |
| Tax % | 24 | 26 | 26 |